Hainan Shuangcheng Pharmaceuticals Co.,Ltd.(002693),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

002693 Hainan Shuangcheng Pharmaceuticals Co.,Ltd.

Closed 12-12 15:00:00

6.88

-0.07

-1.01%

High6.93	Low6.81	Vol5.57M
Open6.90	D1 Closing6.95	Amplitude1.73%
Mkt Cap2.86B	Tradable Cap2.83B	Total Shares415.00M
T/O38.27M	T/O Rate1.35%	Tradable Shares411.00M
P/B7.37	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"002693","market":"SZ","secType":"STK","nameCN":"Hainan Shuangcheng Pharmaceuticals Co.,Ltd.","latestPrice":6.88,"timestamp":1765523031000,"preClose":6.95,"halted":0,"volume":5568900,"delay":0,"changeRate":-0.0101,"floatShares":411000000,"shares":415000000,"eps":-0.1037,"marketStatus":"Closed","change":-0.07,"latestTime":"12-12 15:00:00","open":6.9,"high":6.93,"low":6.81,"amount":38268500,"amplitude":0.0173,"askPrice":6.89,"askSize":257,"bidPrice":6.88,"bidSize":185,"shortable":0,"etf":0,"ttmEps":-0.1037,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1765762200000},"marketStatusCode":5,"adr":0,"adjPreClose":6.95,"symbolType":"stock","openAndCloseTimeList":[[1765503000000,1765510200000],[1765515600000,1765522800000]],"highLimit":7.3,"lowLimit":6.6,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":414689750,"isCdr":false,"pbRate":7.37,"roa":"--","roe":"--","epsLYR":-0.19,"committee":0.433657,"marketValue":2853000000,"turnoverRate":0.0136,"status":1,"nextConnectDate":"Northbound have stopped. The next trading day is UTC+8 2025-12-15.","floatMarketCap":2828000000},"requestUrl":"/m/hq/s/002693","defaultTab":"news","newsList":[{"id":"2576444834","title":"Hainan Shuangcheng Pharmaceuticals Gets License to Produce Anti-HIV, Anticoagulant Injections","url":"https://stock-news.laohu8.com/highlight/detail?id=2576444834","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576444834?lang=en_us&edition=fundamental","pubTime":"2025-10-20 17:09","pubTimestamp":1760951393,"startTime":"0","endTime":"0","summary":"Officials in Hainan, China, granted Shuangcheng Pharmaceuticals  a license to produce Albuvirtide injection for HIV on behalf of Frontier Biopharmaceuticals , according to a Saturday filing with the Shenzhen bourse.Shares closed 2% higher on Monday.The permit is valid for three years.Shuangcheng also obtained approval to produce the Bivalirudin anticoagulant injection on behalf of Suzhou Erye Pharmaceutical, the filing said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["002693","BK0239"],"gpt_icon":0},{"id":"1195436146","title":"Hainan Shuangcheng Pharmaceuticals: All Centralized Procurement Projects This Year Are Renewals","url":"https://stock-news.laohu8.com/highlight/detail?id=1195436146","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195436146?lang=en_us&edition=fundamental","pubTime":"2025-09-25 14:33","pubTimestamp":1758781988,"startTime":"0","endTime":"0","summary":"An investor inquired on the investor interaction platform: \"The company's centralized procurement bid wins increased significantly in the third quarter. Why didn't the company issue corresponding...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["002693","BK0239"],"gpt_icon":0},{"id":"1109128585","title":"*ST Shuangcheng Receives GMP Compliance Inspection Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1109128585","media":"Deep News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109128585?lang=en_us&edition=fundamental","pubTime":"2025-08-26 19:50","pubTimestamp":1756209017,"startTime":"0","endTime":"0","summary":"On August 26, Hainan Shuangcheng Pharmaceuticals Co.,Ltd. (002693) announced that it recently received a \"Drug GMP Compliance Inspection Notice\" approved and issued by the Hainan Provincial Drug...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["002693","BK0239"],"gpt_icon":0},{"id":"2557373719","title":"Shuangcheng Pharmaceuticals Seeks 52 Million Yuan Compensation in Business Trust Dispute With Zhongrong International Trust","url":"https://stock-news.laohu8.com/highlight/detail?id=2557373719","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557373719?lang=en_us&edition=fundamental","pubTime":"2025-08-06 18:53","pubTimestamp":1754477588,"startTime":"0","endTime":"0","summary":"Hainan Shuangcheng Pharmaceuticals  is seeking compensation worth almost 52 million yuan in its lawsuit against Zhongrong International Trust over a business trust dispute, according to a Shenzhen bourse filing on Wednesday.The Chinese pharmaceutical company purchased financial products totaling 50 million yuan from Zhongrong International Trust in 2022 and 2023. The products have been defaulted, but only the partial interest was paid to the company.The amount the company seeks includes 21.1 million yuan in trust proceeds from the B859 Trust Unit and 30.9 million yuan from the A36 Trust Unit.The company's shares dropped over 4% at the close of Wednesday's trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0239","002693"],"gpt_icon":0},{"id":"2556807671","title":"Hainan Shuangcheng Pharmaceuticals Gets Australia Nod for Arginine Vasopressin Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2556807671","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556807671?lang=en_us&edition=fundamental","pubTime":"2025-08-04 17:42","pubTimestamp":1754300532,"startTime":"0","endTime":"0","summary":"Australian authorities granted Hainan Shuangcheng Pharmaceuticals  marketing authorization for its arginine vasopressin injection.The drug is indicated for postoperative abdominal distension, removal of interfering gas shadows in abdominal X-ray examinations, and diabetes insipidus treatment, according to a Saturday filing with the Shenzhen bourse.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0239","XJO.AU","002693","XAO.AU","XKO.AU"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2012-08-08","address":"海南省海口市秀英区兴国路16号","stockEarnings":[{"period":"1week","weight":-0.0072},{"period":"1month","weight":-0.14},{"period":"3month","weight":-0.1179},{"period":"6month","weight":-0.0802},{"period":"1year","weight":-0.696},{"period":"ytd","weight":-0.6247}],"companyName":"海南双成药业股份有限公司","boardCode":"AI0027","perCapita":"9305股","boardName":"医药制造业","registeredCapital":"41468万元","compareEarnings":[{"period":"1week","weight":-0.0034},{"period":"1month","weight":-0.0277},{"period":"3month","weight":0.0048},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1236},{"period":"ytd","weight":0.1604}],"survey":"　　海南双成药业股份有限公司的主营业务是药品注射剂、固体制剂、原料药的研发、生产、销售。公司的主要产品是注射用生长抑素、注射用比伐芦定、依替巴肽注射液、醋酸奥曲肽注射液、注射用紫杉醇(白蛋白结合型)。公司曾荣获国家知识产权示范企业、优势企业奖励。","serverTime":1765702218547,"listedPrice":20,"stockholders":"44166人(较上一季度减少19.43%)","compareStock":{"symbol":"000001.SH","name":"SSE Comp"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Hainan Shuangcheng Pharmaceuticals Co.,Ltd.(002693),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Hainan Shuangcheng Pharmaceuticals Co.,Ltd.(002693) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Hainan Shuangcheng Pharmaceuticals Co.,Ltd.,002693,Hainan Shuangcheng Pharmaceuticals Co.,Ltd.股票,Hainan Shuangcheng Pharmaceuticals Co.,Ltd.股票老虎,Hainan Shuangcheng Pharmaceuticals Co.,Ltd.股票老虎国际,Hainan Shuangcheng Pharmaceuticals Co.,Ltd.行情,Hainan Shuangcheng Pharmaceuticals Co.,Ltd.股票行情,Hainan Shuangcheng Pharmaceuticals Co.,Ltd.股价,Hainan Shuangcheng Pharmaceuticals Co.,Ltd.股市,Hainan Shuangcheng Pharmaceuticals Co.,Ltd.股票价格,Hainan Shuangcheng Pharmaceuticals Co.,Ltd.股票交易,Hainan Shuangcheng Pharmaceuticals Co.,Ltd.股票购买,Hainan Shuangcheng Pharmaceuticals Co.,Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Hainan Shuangcheng Pharmaceuticals Co.,Ltd.(002693),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Hainan Shuangcheng Pharmaceuticals Co.,Ltd.(002693) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction